Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference
Genenta Science (NASDAQ: GNTA) has announced its participation in the D. Boral Capital Inaugural Global Conference on May 14, 2025, at The Plaza Hotel in New York City. The company's Chief Medical Officer, Carlo Russo, will be available for one-on-one meetings from 9:00 A.M. to 3:00 P.M. (ET). Interested parties can schedule meetings by contacting John Perez at [email protected].
Genenta Science (NASDAQ: GNTA) ha annunciato la sua partecipazione al D. Boral Capital Inaugural Global Conference che si terr脿 il 14 maggio 2025 presso il The Plaza Hotel di New York City. Il Chief Medical Officer dell'azienda, Carlo Russo, sar脿 disponibile per incontri individuali dalle 9:00 alle 15:00 (ET). Gli interessati possono fissare un appuntamento contattando John Perez all'indirizzo [email protected].
Genenta Science (NASDAQ: GNTA) ha anunciado su participaci贸n en la D. Boral Capital Inaugural Global Conference el 14 de mayo de 2025, en The Plaza Hotel en la ciudad de Nueva York. El Director M茅dico de la empresa, Carlo Russo, estar谩 disponible para reuniones individuales de 9:00 a.m. a 3:00 p.m. (ET). Las partes interesadas pueden programar reuniones contactando a John Perez en [email protected].
Genenta Science (NASDAQ: GNTA)电� 2025雲� 5鞗� 14鞚� 雺挫殨鞁� The Plaza Hotel鞐愳劀 鞐措Μ电� D. Boral Capital Inaugural Global Conference鞐� 彀戈皜頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. 須岇偓鞚� 斓滉碃 鞚橅暀 毂呾瀯鞛� Carlo Russo电� 鞓れ爠 9鞁滊秬韯� 鞓ろ泟 3鞁�(霃欕秬 鞁滉皠)旯岇 1:1 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�. 甏�鞁� 鞛埖鐢 攵勲摛鞚� [email protected]鞙茧 John Perez鞐愱矊 鞐半澖頃� 氙疙寘鞚� 鞓堨暯頃� 靾� 鞛堨姷雼堧嫟.
Genenta Science (NASDAQ : GNTA) a annonc茅 sa participation 脿 la D. Boral Capital Inaugural Global Conference qui se tiendra le 14 mai 2025 au The Plaza Hotel 脿 New York. Le directeur m茅dical de l'entreprise, Carlo Russo, sera disponible pour des rendez-vous individuels de 9h00 脿 15h00 (heure de l'Est). Les personnes int茅ress茅es peuvent prendre rendez-vous en contactant John Perez 脿 l'adresse [email protected].
Genenta Science (NASDAQ: GNTA) hat seine Teilnahme an der D. Boral Capital Inaugural Global Conference am 14. Mai 2025 im The Plaza Hotel in New York City angek眉ndigt. Der Chief Medical Officer des Unternehmens, Carlo Russo, steht von 9:00 bis 15:00 Uhr (ET) f眉r Einzelgespr盲che zur Verf眉gung. Interessierte k枚nnen Termine vereinbaren, indem sie John Perez unter [email protected] kontaktieren.
- None.
- None.
Milan, Italy and New York, New York--(Newsfile Corp. - May 8, 2025) - Genenta Science, SpA (NASDAQ: GNTA), today announced its participation in the D. Boral Capital Inaugural Global Conference, taking place May 14, 2025, at The Plaza Hotel in New York City.
Carlo Russo, Chief Medical Officier, will be hosting one-on-one meetings on May 14th from 9:00 A.M. to 3:00 P.M. (ET).
To register for one-on-one meetings with management at The Plaza Hotel in New York City, interested parties should contact John Perez at [email protected].
About Genenta Science, SpA
Genenta (NASDAQ: GNTA) is a clinical stage immuno-oncology company developing a proprietary hematopoietic stem cells therapy for the treatment of a variety of solid tumor cancers. Genenta first in class product candidate is Temferon™, which is designed to allow the expression of immune-therapeutic payloads within the tumor microenvironment by bone marrow derived myeloid cells and enable a durable and targeted response. Genenta has completed the Phase 1 trial for newly diagnosed Glioblastoma Multiforme patients with an unmethylated MGMT gene promoter, which suggests the potential reprogramming of the tumor microenvironment and inhibiting of myeloid induced tolerance, while allowing the induction of T cell responses, potentially breaking immune tolerance. Genenta has initiated in Q4 2024 a Phase 1/2a metastatic Renal Cell Carcinoma study that will also include a combination with immune checkpoint inhibitors. Genenta’s treatments are designed as one-time monotherapies, but with the additional potential, when used in combination, to significantly enhance the efficacy of other approved therapeutics.
About D. Boral Capital
D. Boral Capital LLC is an investment bank headquartered in New York which provides advisory and financing solutions to middle market and emerging growth companies. The Company has a proven track record of offering strategic guidance to clients across the globe in any sector, with access to capital from the USA, Asia, Europe, Middle East, and Latin America.
D. Boral Capital is a leader on Wall Street, having aggregated over
For further information:
Genenta Science, SpA
Tiziana Pollio
Communications
+393482315143
[email protected]
Source Genenta Science, SpA
FAQ
When is Genenta Science (GNTA) participating in the D. Boral Capital Conference?
Who will represent Genenta Science (GNTA) at the D. Boral Capital Conference?
What are the meeting hours for Genenta Science (GNTA) at the D. Boral Capital Conference?
How can investors schedule meetings with Genenta Science (GNTA) management at the conference?
